193 related articles for article (PubMed ID: 21856791)
1. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
Yesilyurt M; Kiliç S; Celebi B; Celik M; Gül S; Erdogan F; Ozel G
J Antimicrob Chemother; 2011 Nov; 66(11):2588-92. PubMed ID: 21856791
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Tomaso H; Al Dahouk S; Hofer E; Splettstoesser WD; Treu TM; Dierich MP; Neubauer H
Int J Antimicrob Agents; 2005 Oct; 26(4):279-84. PubMed ID: 16143497
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
Kiliç S; Celebi B; Acar B; Ataş M
Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe.
Kreizinger Z; Makrai L; Helyes G; Magyar T; Erdélyi K; Gyuranecz M
J Antimicrob Chemother; 2013 Feb; 68(2):370-3. PubMed ID: 23065699
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
Caspar Y; Hennebique A; Maurin M
J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
[TBL] [Abstract][Full Text] [Related]
6. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
Georgi E; Schacht E; Scholz HC; Splettstoesser WD
J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
[TBL] [Abstract][Full Text] [Related]
8. [In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
Ulu Kılıç A; Kılıç S; Celebi B; Sencan I
Mikrobiyol Bul; 2013 Jan; 47(1):189-91. PubMed ID: 23390918
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents.
García del Blanco N; Gutiérrez Martín CB; de la Puente Redondo VA; Rodríguez Ferri EF
Res Vet Sci; 2004 Jun; 76(3):195-8. PubMed ID: 15046952
[TBL] [Abstract][Full Text] [Related]
10.
Caspar Y; Maurin M
Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the Turkish isolates of Francisella tularensis.
Gurcan S; Karabay O; Karadenizli A; Karagol C; Kantardjiev T; Ivanov IN
Jpn J Infect Dis; 2008 May; 61(3):223-5. PubMed ID: 18503176
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals.
Ikäheimo I; Syrjälä H; Karhukorpi J; Schildt R; Koskela M
J Antimicrob Chemother; 2000 Aug; 46(2):287-90. PubMed ID: 10933655
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents.
Scheel O; Hoel T; Sandvik T; Berdal BP
APMIS; 1993 Jan; 101(1):33-6. PubMed ID: 8384458
[TBL] [Abstract][Full Text] [Related]
14. [A water-borne tularemia outbreak caused by Francisella tularensis subspecies holarctica in Central Anatolia region].
Ulu Kılıç A; Kılıç S; Sencan I; Ciçek Şentürk G; Gürbüz Y; Tütüncü EE; Celebi B; Kıcıman Ö; Ergönül Ö
Mikrobiyol Bul; 2011 Apr; 45(2):234-47. PubMed ID: 21644066
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013.
Origgi FC; Frey J; Pilo P
Euro Surveill; 2014 Jul; 19(29):. PubMed ID: 25080140
[TBL] [Abstract][Full Text] [Related]
16. Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.
Caspar Y; Sutera V; Boisset S; Denis JN; Maurin M
Front Cell Infect Microbiol; 2014; 4():24. PubMed ID: 24579066
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method.
Valade E; Vaissaire J; Mérens A; Hernandez E; Gros C; Le Doujet C; Paucod JC; Thibault FM; Durand B; Lapalus M; Dupuis I; Caclard A; Vidal DR; Cavallo JD
J Antimicrob Chemother; 2008 Jul; 62(1):208-10. PubMed ID: 18397924
[No Abstract] [Full Text] [Related]
18. [Francisella tularensis and tularemia in Turkey].
Gürcan S
Mikrobiyol Bul; 2007 Oct; 41(4):621-36. PubMed ID: 18173084
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
Urich SK; Petersen JM
Antimicrob Agents Chemother; 2008 Jun; 52(6):2276-8. PubMed ID: 18411318
[TBL] [Abstract][Full Text] [Related]
20. Septic pneumonic tularaemia caused by Francisella tularensis subsp. holarctica biovar II.
Fritzsch J; Splettstoesser WD
J Med Microbiol; 2010 Sep; 59(Pt 9):1123-1125. PubMed ID: 20522628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
